Landscape analysis and overview of the literature on oxidative stress and pulmonary diseases
Oxidative stress is caused by an imbalance in oxidant/antioxidant processes and is a critical process in pulmonary diseases. As no truly effective therapies exist for lung cancer, lung fibrosis and chronic obstructive pulmonary disease (COPD), at present, it is important to comprehensively study the...
Saved in:
| Published in | Frontiers in pharmacology Vol. 14; p. 1190817 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
Frontiers Media S.A
26.05.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Oxidative stress is caused by an imbalance in oxidant/antioxidant processes and is a critical process in pulmonary diseases. As no truly effective therapies exist for lung cancer, lung fibrosis and chronic obstructive pulmonary disease (COPD), at present, it is important to comprehensively study the relationship between oxidative stress and pulmonary diseases to identify truly effective therapeutics. Since there is no quantitative and qualitative bibliometric analysis of the literature in this area, this review provides an in-depth analysis of publications related to oxidative stress and pulmonary diseases over four periods, including from 1953 to 2007, 2008 to 2012, 2013 to 2017, and 2018 to 2022. Interest in many pulmonary diseases has increased, and the mechanisms and therapeutic drugs for pulmonary diseases have been well analyzed. Lung injury, lung cancer, asthma, COPD and pneumonia are the 5 most studied pulmonary diseases related to oxidative stress. Inflammation, apoptosis, nuclear factor erythroid 2 like 2 (NRF2), mitochondria, and nuclear factor-κB (NF-κB) are rapidly becoming the most commonly used top keywords. The top thirty medicines most studied for treating different pulmonary diseases were summarized. Antioxidants, especially those targeting reactive oxygen species (ROS) in specific organelles and certain diseases, may be a substantial and necessary choice in combined therapies rather than acting as a single “magic bullet” for the effective treatment of refractory pulmonary diseases. |
|---|---|
| AbstractList | Oxidative stress is caused by an imbalance in oxidant/antioxidant processes and is a critical process in pulmonary diseases. As no truly effective therapies exist for lung cancer, lung fibrosis and chronic obstructive pulmonary disease (COPD), at present, it is important to comprehensively study the relationship between oxidative stress and pulmonary diseases to identify truly effective therapeutics. Since there is no quantitative and qualitative bibliometric analysis of the literature in this area, this review provides an in-depth analysis of publications related to oxidative stress and pulmonary diseases over four periods, including from 1953 to 2007, 2008 to 2012, 2013 to 2017, and 2018 to 2022. Interest in many pulmonary diseases has increased, and the mechanisms and therapeutic drugs for pulmonary diseases have been well analyzed. Lung injury, lung cancer, asthma, COPD and pneumonia are the 5 most studied pulmonary diseases related to oxidative stress. Inflammation, apoptosis, nuclear factor erythroid 2 like 2 (NRF2), mitochondria, and nuclear factor-κB (NF-κB) are rapidly becoming the most commonly used top keywords. The top thirty medicines most studied for treating different pulmonary diseases were summarized. Antioxidants, especially those targeting reactive oxygen species (ROS) in specific organelles and certain diseases, may be a substantial and necessary choice in combined therapies rather than acting as a single “magic bullet” for the effective treatment of refractory pulmonary diseases. Oxidative stress is caused by an imbalance in oxidant/antioxidant processes and is a critical process in pulmonary diseases. As no truly effective therapies exist for lung cancer, lung fibrosis and chronic obstructive pulmonary disease (COPD), at present, it is important to comprehensively study the relationship between oxidative stress and pulmonary diseases to identify truly effective therapeutics. Since there is no quantitative and qualitative bibliometric analysis of the literature in this area, this review provides an in-depth analysis of publications related to oxidative stress and pulmonary diseases over four periods, including from 1953 to 2007, 2008 to 2012, 2013 to 2017, and 2018 to 2022. Interest in many pulmonary diseases has increased, and the mechanisms and therapeutic drugs for pulmonary diseases have been well analyzed. Lung injury, lung cancer, asthma, COPD and pneumonia are the 5 most studied pulmonary diseases related to oxidative stress. Inflammation, apoptosis, nuclear factor erythroid 2 like 2 (NRF2), mitochondria, and nuclear factor-κB (NF-κB) are rapidly becoming the most commonly used top keywords. The top thirty medicines most studied for treating different pulmonary diseases were summarized. Antioxidants, especially those targeting reactive oxygen species (ROS) in specific organelles and certain diseases, may be a substantial and necessary choice in combined therapies rather than acting as a single "magic bullet" for the effective treatment of refractory pulmonary diseases.Oxidative stress is caused by an imbalance in oxidant/antioxidant processes and is a critical process in pulmonary diseases. As no truly effective therapies exist for lung cancer, lung fibrosis and chronic obstructive pulmonary disease (COPD), at present, it is important to comprehensively study the relationship between oxidative stress and pulmonary diseases to identify truly effective therapeutics. Since there is no quantitative and qualitative bibliometric analysis of the literature in this area, this review provides an in-depth analysis of publications related to oxidative stress and pulmonary diseases over four periods, including from 1953 to 2007, 2008 to 2012, 2013 to 2017, and 2018 to 2022. Interest in many pulmonary diseases has increased, and the mechanisms and therapeutic drugs for pulmonary diseases have been well analyzed. Lung injury, lung cancer, asthma, COPD and pneumonia are the 5 most studied pulmonary diseases related to oxidative stress. Inflammation, apoptosis, nuclear factor erythroid 2 like 2 (NRF2), mitochondria, and nuclear factor-κB (NF-κB) are rapidly becoming the most commonly used top keywords. The top thirty medicines most studied for treating different pulmonary diseases were summarized. Antioxidants, especially those targeting reactive oxygen species (ROS) in specific organelles and certain diseases, may be a substantial and necessary choice in combined therapies rather than acting as a single "magic bullet" for the effective treatment of refractory pulmonary diseases. |
| Author | Wang, Xiaofan Cao, Pengxiu Liu, Xin Zhang, Hongmin Chang, Jing |
| AuthorAffiliation | Ministry of Education Key Laboratory of Molecular and Cellular Biology , Hebei Key Laboratory of Animal Physiology, Biochemistry, and Molecular Biology , College of Life Sciences , Hebei Normal University , Shijiazhuang , Hebei , China |
| AuthorAffiliation_xml | – name: Ministry of Education Key Laboratory of Molecular and Cellular Biology , Hebei Key Laboratory of Animal Physiology, Biochemistry, and Molecular Biology , College of Life Sciences , Hebei Normal University , Shijiazhuang , Hebei , China |
| Author_xml | – sequence: 1 givenname: Xin surname: Liu fullname: Liu, Xin – sequence: 2 givenname: Xiaofan surname: Wang fullname: Wang, Xiaofan – sequence: 3 givenname: Jing surname: Chang fullname: Chang, Jing – sequence: 4 givenname: Hongmin surname: Zhang fullname: Zhang, Hongmin – sequence: 5 givenname: Pengxiu surname: Cao fullname: Cao, Pengxiu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37305540$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UktvEzEQtlARLaF_gAPaI5cEv3d9QqjiUSkSF7ghWY49blxt7MX2BvrvcZpQtRzwxSP7e4xmvpfoLKYICL0meMXYoN75aWvyimLKVoQoPJD-GbogUrKlGgg9e1Sfo8tSbnE7TCkm-Qt0znqGheD4Av1Ym-iKNRN0JprxroTSCtelPeR9gF9d8l3dQjeGCtnUOUOXYpd-B2dq2ENXaoZypEzzuEvR5LvOhQKmQHmFnnszFrg83Qv0_dPHb1dfluuvn6-vPqyXlktVl5J7z3oihSBeYs-8p9hunHGql4RwKZhXjBEDnjPZM8csIYIouuk5I7xNYIGuj7oumVs95bBrXehkgr5_SPlGm1yDHUEr2ntqXDNiA1fCKMq99T1YOvhBYtG03h-1pnmzA2ch1mzGJ6JPf2LY6pu01wRTgUWb8AK9PSnk9HOGUvUuFAvjaCKkuWg6UEGE6CVu0DePzR5c_u6nAegRYHMqJYN_gBCsDznQ9znQhxzoUw4aafiHZENt60qHhsP4P-ofqXS5aQ |
| CitedBy_id | crossref_primary_10_1097_MD_0000000000039883 crossref_primary_10_1142_S0192415X25500041 crossref_primary_10_1165_rcmb_2024_0219OC crossref_primary_10_3390_antiox13091106 crossref_primary_10_3389_fnut_2025_1541559 crossref_primary_10_1038_s41598_024_81913_x crossref_primary_10_3390_cryptography9010017 |
| Cites_doi | 10.1155/2016/7432797 10.14670/HH-30.523 10.3389/fimmu.2020.01957 10.1002/jat.4469 10.1016/j.bbadis.2012.11.021 10.1186/s12931-018-0766-3 10.1016/j.jep.2020.112653 10.1016/j.bbrc.2019.08.165 10.1017/S0007114515002597 10.1016/j.neuint.2011.10.005 10.22088/IJMCM.BUMS.7.4.212 10.1089/ars.2013.5469 10.1016/j.redox.2015.09.005 10.1038/s41419-017-0198-x 10.1007/s00775-005-0019-z 10.1155/2017/8416763 10.1097/01.CCM.0000050284.35609.97 10.3390/ijerph10093886 10.1038/nprot.2009.197 10.1038/s41467-019-10991-7 10.1111/j.1742-4658.2008.06542.x 10.1089/ars.2007.1993 10.1016/j.biopha.2023.114637 10.1016/j.freeradbiomed.2010.09.006 10.1016/j.freeradbiomed.2020.12.233 10.1371/journal.pone.0096285 10.1016/j.taap.2020.114913 10.1016/j.prrv.2020.09.003 10.3892/mmr.2018.8923 10.1038/s41591-018-0087-6 10.1155/2019/7092151 10.1182/blood.v91.9.3459.3459_3459_3466 10.1378/chest.12-2664 10.1186/s12967-017-1306-5 10.1111/j.1743-6109.2008.00804.x 10.1007/s00408-016-9946-4 10.2147/COPD.S164151 10.1038/nature24637 10.1002/cti2.1019 10.1007/s10787-020-00707-5 10.1016/j.intimp.2019.105755 10.1371/journal.pmed.0030420 10.1016/j.redox.2019.101307 10.1042/CS20160487 10.1002/path.5401 10.1038/srep38646 10.3892/ijmm.2018.3965 10.1080/10715769900300881 10.3390/nu10111614 10.1016/j.toxlet.2020.06.005 10.3390/molecules24081583 10.1002/iub.1976 10.1002/med.21396 10.2174/1570159x19666201230144109 10.1002/jcp.27767 10.1097/QAI.0000000000003125 10.3390/ph12010005 10.1016/j.bbamcr.2018.02.010 10.1016/j.redox.2015.07.012 10.1007/s12017-018-08523-5 10.1016/j.fct.2018.02.013 10.1016/j.canlet.2018.06.028 10.3389/fimmu.2019.02787 10.1016/j.jaci.2015.01.046 10.1158/1541-7786.MCR-20-0108 10.1016/s0891-5849(96)00501-1 10.1038/nm.4447 10.18632/aging.103378 10.1016/j.toxlet.2022.11.022 10.1161/CIRCRESAHA.117.311401 10.1016/j.freeradbiomed.2018.09.014 10.1016/j.redox.2017.11.006 10.3390/nu12061742 10.1186/1465-9921-9-10 10.1536/ihj.18-476 10.1016/j.ejcb.2019.151058 10.1055/s-0033-1363468 10.1016/j.reprotox.2012.08.001 10.1186/s11658-020-00205-0 10.1183/09031936.00154006 10.2174/1381612825666190215121712 10.1016/j.mam.2011.10.006 10.1016/j.mam.2018.08.001 10.1016/j.tice.2022.101953 |
| ContentType | Journal Article |
| Copyright | Copyright © 2023 Liu, Wang, Chang, Zhang and Cao. Copyright © 2023 Liu, Wang, Chang, Zhang and Cao. 2023 Liu, Wang, Chang, Zhang and Cao |
| Copyright_xml | – notice: Copyright © 2023 Liu, Wang, Chang, Zhang and Cao. – notice: Copyright © 2023 Liu, Wang, Chang, Zhang and Cao. 2023 Liu, Wang, Chang, Zhang and Cao |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3389/fphar.2023.1190817 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| DocumentTitleAlternate | Liu et al |
| EISSN | 1663-9812 |
| ExternalDocumentID | oai_doaj_org_article_927f2ad1f638495a924fcf7ec28f8605 PMC10250599 37305540 10_3389_fphar_2023_1190817 |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: ; grantid: 31900817 32071119 |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM IAO IEA IHR IHW IPNFZ NPM RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c469t-64ff3716551f60f3ff20cbdad976114653f9331aef43673d3c115192b74314023 |
| IEDL.DBID | M48 |
| ISSN | 1663-9812 |
| IngestDate | Wed Aug 27 01:24:27 EDT 2025 Thu Aug 21 18:37:50 EDT 2025 Thu Jul 10 17:13:18 EDT 2025 Thu Jan 02 22:51:13 EST 2025 Tue Jul 01 02:53:07 EDT 2025 Thu Apr 24 22:57:46 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | antioxidants inflammation pulmonary disease mitochondria oxidative stress |
| Language | English |
| License | Copyright © 2023 Liu, Wang, Chang, Zhang and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c469t-64ff3716551f60f3ff20cbdad976114653f9331aef43673d3c115192b74314023 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Edited by: Sabina Antonela Antoniu, Grigore T. Popa University of Medicine and Pharmacy, Romania These authors have contributed equally to this work Antigona Trofor, Grigore T. Popa University of Medicine and Pharmacy, Romania Reviewed by: Stefan Hadzic, University of Giessen, Germany |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2023.1190817 |
| PMID | 37305540 |
| PQID | 2825155760 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_927f2ad1f638495a924fcf7ec28f8605 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10250599 proquest_miscellaneous_2825155760 pubmed_primary_37305540 crossref_primary_10_3389_fphar_2023_1190817 crossref_citationtrail_10_3389_fphar_2023_1190817 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-05-26 |
| PublicationDateYYYYMMDD | 2023-05-26 |
| PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-26 day: 26 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in pharmacology |
| PublicationTitleAlternate | Front Pharmacol |
| PublicationYear | 2023 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Muratani (B48) 2023 Steven (B67) 2019; 2019 Itoh (B32) 1999; 31 Margis (B44) 2008; 275 Bellezza (B7) 2018; 1865 Wiegman (B78) 2015; 136 Lewis (B36) 2019; 71 Bahn (B5) 2019; 21 Lu (B42) 2016; 36 Philippot (B51) 2014; 9 Han (B26) 2023; 162 Gu (B24) 2023; 374 Prashanth Goud (B53) 2019; 75 Tuleta (B70) 2016; 194 Lippi (B38) 2014; 40 Amini (B3) 2018; 7 Flohe (B18) 1997; 22 Neves (B49) 2019; 12 Raghu (B56) 2020; 19 Ali (B1) 2020; 251 Pulivendala (B54) 2020; 391 Ge (B20) 2019; 60 Lu (B41) 2005; 10 Chen (B10) 2018; 7 Dong (B15) 2020; 12 Owusu (B50) 2020; 164 Pizzino (B52) 2017; 2017 Zhou (B84) 2016; 6 Ghio (B21) 2003; 31 Goldkorn (B23) 2014; 21 Hussain (B29) 2016; 2016 Klaunig (B34) 2018; 24 Dianat (B14) 2018; 19 Yu (B80) 2018; 24 Ghio (B22) 2008; 9 Fan (B17) 2019; 234 Gu (B25) 2019; 26 Forrester (B19) 2018; 122 Malinska (B43) 2018; 115 van der Vliet (B73) 2018; 63 Wiegman (B77) 2020; 11 Cheresh (B11) 2013; 1832 Mokhtari-Zaer (B47) 2020; 253 Singh (B64) 2019; 24 Helmig (B27) 2018; 17 Hybertson (B30) 2011; 32 Duecker (B16) 2018; 14 Uchiyama (B71) 2020; 331 Zhang (B81) 2018; 9 Dan Dunn (B13) 2015; 6 Tostes (B69) 2008; 5 Liu (B40) 2017; 15 Conte (B12) 2015; 30 Rajasekar (B57) 2020; 28 Wang (B74) 2020; 99 Tian (B68) 2020; 18 Yoshida (B79) 2019; 10 Bhatt (B8) 2020; 36 Rangarajan (B58) 2018; 24 Bahl (B4) 2012; 34 Staitieh (B66) 2023; 92 Schmitt (B62) 2015; 6 Alvarez (B2) 2017; 551 Impellizzeri (B31) 2015; 114 Liu (B39) 2020; 25 Chatterjee (B9) 2018; 433 Singh (B65) 2006; 3 Martinez (B46) 2009; 11 Weydert (B76) 2009; 5 Li (B37) 2019; 519 Reuter (B60) 2010; 49 Seibt (B63) 2019; 133 Kirkham (B33) 2013; 144 Zheng (B82) 2019; 43 Zhou (B83) 2018; 13 Lee (B35) 2018; 10 Valavanidis (B72) 2013; 10 Martin (B45) 1998; 91 Wang (B75) 2022; 79 Sachdeva (B61) 2019; 10 Reid (B59) 2007; 30 Barnes (B6) 2017; 131 Huang (B28) 2020; 12 Qu (B55) 2011; 59 |
| References_xml | – volume: 2016 start-page: 7432797 year: 2016 ident: B29 article-title: Oxidative stress and inflammation: What polyphenols can do for us? publication-title: Oxid. Med. Cell Longev. doi: 10.1155/2016/7432797 – volume: 30 start-page: 523 year: 2015 ident: B12 article-title: Anti-inflammatory and antifibrotic effects of resveratrol in the lung publication-title: Histology Histopathol. doi: 10.14670/HH-30.523 – volume: 11 start-page: 1957 year: 2020 ident: B77 article-title: Oxidative stress in ozone-induced chronic lung inflammation and emphysema: A facet of chronic obstructive pulmonary disease publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.01957 – year: 2023 ident: B48 article-title: Oxidative stress-mediated epidermal growth factor receptor activation by cigarette smoke or heated tobacco aerosol in human primary bronchial epithelial cells from multiple donors publication-title: J. Appl. Toxicol. doi: 10.1002/jat.4469 – volume: 1832 start-page: 1028 year: 2013 ident: B11 article-title: Oxidative stress and pulmonary fibrosis publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2012.11.021 – volume: 19 start-page: 58 year: 2018 ident: B14 article-title: Crocin attenuates cigarette smoke-induced lung injury and cardiac dysfunction by anti-oxidative effects: The role of Nrf2 antioxidant system in preventing oxidative stress publication-title: Respir. Res. doi: 10.1186/s12931-018-0766-3 – volume: 253 start-page: 112653 year: 2020 ident: B47 article-title: The protective effect of Nigella sativa extract on lung inflammation and oxidative stress induced by lipopolysaccharide in rats publication-title: J. Ethnopharmacol. doi: 10.1016/j.jep.2020.112653 – volume: 519 start-page: 240 year: 2019 ident: B37 article-title: Role of ferroptosis in the process of acute radiation-induced lung injury in mice publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2019.08.165 – volume: 114 start-page: 853 year: 2015 ident: B31 article-title: Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice publication-title: Br. J. Nutr. doi: 10.1017/S0007114515002597 – volume: 59 start-page: 1095 year: 2011 ident: B55 article-title: Lycopene protects against trimethyltin-induced neurotoxicity in primary cultured rat hippocampal neurons by inhibiting the mitochondrial apoptotic pathway publication-title: Neurochem. Int. doi: 10.1016/j.neuint.2011.10.005 – volume: 7 start-page: 212 year: 2018 ident: B3 article-title: Curcumin mitigates radiation-induced lung pneumonitis and fibrosis in rats publication-title: Int. J. Mol. Cell. Med. doi: 10.22088/IJMCM.BUMS.7.4.212 – volume: 21 start-page: 2149 year: 2014 ident: B23 article-title: Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor publication-title: Antioxid. Redox Signal doi: 10.1089/ars.2013.5469 – volume: 6 start-page: 472 year: 2015 ident: B13 article-title: Reactive oxygen species and mitochondria: A nexus of cellular homeostasis publication-title: Redox Biol. doi: 10.1016/j.redox.2015.09.005 – volume: 9 start-page: 83 year: 2018 ident: B81 article-title: Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis publication-title: Cell death Dis. doi: 10.1038/s41419-017-0198-x – volume: 10 start-page: 732 year: 2005 ident: B41 article-title: Inhibition of the Fenton reaction by nitrogen monoxide publication-title: J. Biol. Inorg. Chem. doi: 10.1007/s00775-005-0019-z – volume: 2017 start-page: 8416763 year: 2017 ident: B52 article-title: Oxidative stress: Harms and benefits for human health publication-title: Oxidative Med. Cell. Longev. doi: 10.1155/2017/8416763 – volume: 31 start-page: 395 year: 2003 ident: B21 article-title: Iron and iron-related proteins in the lower respiratory tract of patients with acute respiratory distress syndrome publication-title: Crit. Care Med. doi: 10.1097/01.CCM.0000050284.35609.97 – volume: 10 start-page: 3886 year: 2013 ident: B72 article-title: Pulmonary oxidative stress, inflammation and cancer: Respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms publication-title: Int. J. Environ. Res. Public Health doi: 10.3390/ijerph10093886 – volume: 5 start-page: 51 year: 2009 ident: B76 article-title: Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue publication-title: Nat. Protoc. doi: 10.1038/nprot.2009.197 – volume: 10 start-page: 3145 year: 2019 ident: B79 article-title: Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis publication-title: Nat. Commun. doi: 10.1038/s41467-019-10991-7 – volume: 275 start-page: 3959 year: 2008 ident: B44 article-title: Glutathione peroxidase family - an evolutionary overview publication-title: FEBS J. doi: 10.1111/j.1742-4658.2008.06542.x – volume: 11 start-page: 669 year: 2009 ident: B46 article-title: Reactive nitrogen species: Molecular mechanisms and potential significance in health and disease publication-title: Antioxid. Redox Signal doi: 10.1089/ars.2007.1993 – volume: 162 start-page: 114637 year: 2023 ident: B26 article-title: Diesel vehicles-derived PM2.5 induces lung and cardiovascular injury attenuates by Securiniga suffruticosa: Involvement of NF-κB-mediated NLRP3 inflammasome activation pathway publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2023.114637 – volume: 49 start-page: 1603 year: 2010 ident: B60 article-title: Oxidative stress, inflammation, and cancer: How are they linked? publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2010.09.006 – volume: 164 start-page: 76 year: 2020 ident: B50 article-title: Radiation-induced reactive oxygen species partially assemble neutrophil NADPH oxidase publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2020.12.233 – volume: 9 start-page: e96285 year: 2014 ident: B51 article-title: Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease publication-title: PLoS One doi: 10.1371/journal.pone.0096285 – volume: 391 start-page: 114913 year: 2020 ident: B54 article-title: Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo publication-title: Toxicol. Appl. Pharmacol. doi: 10.1016/j.taap.2020.114913 – volume: 36 start-page: 75 year: 2020 ident: B8 article-title: An update on controversies in e-cigarettes publication-title: Paediatr. Respir. Rev. doi: 10.1016/j.prrv.2020.09.003 – volume: 17 start-page: 8518 year: 2018 ident: B27 article-title: Oxidative and cytotoxic stress induced by inorganic granular and fibrous particles publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2018.8923 – volume: 24 start-page: 1121 year: 2018 ident: B58 article-title: Metformin reverses established lung fibrosis in a bleomycin model publication-title: Nat. Med. doi: 10.1038/s41591-018-0087-6 – volume: 2019 start-page: 7092151 year: 2019 ident: B67 article-title: Vascular inflammation and oxidative stress: Major triggers for cardiovascular disease publication-title: Oxidative Med. Cell. Longev. doi: 10.1155/2019/7092151 – volume: 91 start-page: 3459 year: 1998 ident: B45 article-title: Erythroid maturation and globin gene expression in mice with combined deficiency of NF-E2 and nrf-2 publication-title: Blood doi: 10.1182/blood.v91.9.3459.3459_3459_3466 – volume: 144 start-page: 266 year: 2013 ident: B33 article-title: Oxidative stress in COPD publication-title: Chest doi: 10.1378/chest.12-2664 – volume: 15 start-page: 207 year: 2017 ident: B40 article-title: The pathophysiological role of mitochondrial oxidative stress in lung diseases publication-title: J. Transl. Med. doi: 10.1186/s12967-017-1306-5 – volume: 5 start-page: 1284 year: 2008 ident: B69 article-title: Cigarette smoking and erectile dysfunction: Focus on NO bioavailability and ROS generation publication-title: J. Sex. Med. doi: 10.1111/j.1743-6109.2008.00804.x – volume: 194 start-page: 1015 year: 2016 ident: B70 article-title: Intermittent hypoxia contributes to the lung damage by increased oxidative stress, inflammation, and disbalance in protease/antiprotease system publication-title: Lung doi: 10.1007/s00408-016-9946-4 – volume: 13 start-page: 2131 year: 2018 ident: B83 article-title: Over-expression of nuclear factor-κB family genes and inflammatory molecules is related to chronic obstructive pulmonary disease publication-title: Int. J. chronic Obstr. Pulm. Dis. doi: 10.2147/COPD.S164151 – volume: 551 start-page: 639 year: 2017 ident: B2 article-title: NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis publication-title: Nature doi: 10.1038/nature24637 – volume: 7 start-page: e1019 year: 2018 ident: B10 article-title: Oxidative and endoplasmic reticulum stress in respiratory disease publication-title: Clin. Transl. Immunol. doi: 10.1002/cti2.1019 – volume: 28 start-page: 1301 year: 2020 ident: B57 article-title: Tannic acid alleviates experimental pulmonary fibrosis in mice by inhibiting inflammatory response and fibrotic process publication-title: Inflammopharmacology doi: 10.1007/s10787-020-00707-5 – volume: 75 start-page: 105755 year: 2019 ident: B53 article-title: Therapeutic effects of Nimbolide, an autophagy regulator, in ameliorating pulmonary fibrosis through attenuation of TGF-β1 driven epithelial-to-mesenchymal transition publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2019.105755 – volume: 3 start-page: e420 year: 2006 ident: B65 article-title: Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer publication-title: PLoS Med. doi: 10.1371/journal.pmed.0030420 – volume: 26 start-page: 101307 year: 2019 ident: B25 article-title: Mitochondrial calcium uniporter regulates PGC-1α expression to mediate metabolic reprogramming in pulmonary fibrosis publication-title: Redox Biol. doi: 10.1016/j.redox.2019.101307 – volume: 131 start-page: 1541 year: 2017 ident: B6 article-title: Cellular and molecular mechanisms of asthma and COPD publication-title: Clin. Sci. doi: 10.1042/CS20160487 – volume: 251 start-page: 49 year: 2020 ident: B1 article-title: Critical role for iron accumulation in the pathogenesis of fibrotic lung disease publication-title: J. Pathol. doi: 10.1002/path.5401 – volume: 6 start-page: 38646 year: 2016 ident: B84 article-title: Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis publication-title: Sci. Rep. doi: 10.1038/srep38646 – volume: 43 start-page: 117 year: 2019 ident: B82 article-title: Isorhamnetin protects against bleomycin-induced pulmonary fibrosis by inhibiting endoplasmic reticulum stress and epithelial-mesenchymal transition publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2018.3965 – volume: 31 start-page: 319 year: 1999 ident: B32 article-title: Regulatory mechanisms of cellular response to oxidative stress publication-title: Free Radic. Res. doi: 10.1080/10715769900300881 – volume: 10 start-page: 1614 year: 2018 ident: B35 article-title: The role of vitamin E in immunity publication-title: Nutrients doi: 10.3390/nu10111614 – volume: 331 start-page: 227 year: 2020 ident: B71 article-title: New phenotypic cytotoxicity assay for ROS-inducing compounds using rat renal epithelial cells publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2020.06.005 – volume: 24 start-page: 1583 year: 2019 ident: B64 article-title: Oxidative stress: A key modulator in neurodegenerative diseases publication-title: Molecules doi: 10.3390/molecules24081583 – volume: 71 start-page: 487 year: 2019 ident: B36 article-title: Regulatory role of vitamin E in the immune system and inflammation publication-title: IUBMB life doi: 10.1002/iub.1976 – volume: 36 start-page: 924 year: 2016 ident: B42 article-title: The keap1-nrf2-ARE pathway as a potential preventive and therapeutic target: An update publication-title: Med. Res. Rev. doi: 10.1002/med.21396 – volume: 19 start-page: 1202 year: 2020 ident: B56 article-title: The multifaceted therapeutic role of N-acetylcysteine (NAC) in disorders characterized by oxidative stress publication-title: Curr. Neuropharmacol. doi: 10.2174/1570159x19666201230144109 – volume: 234 start-page: 7695 year: 2019 ident: B17 article-title: Roles of Nrf2/HO-1 and HIF-1α/VEGF in lung tissue injury and repair following cerebral ischemia/reperfusion injury publication-title: J. Cell Physiol. doi: 10.1002/jcp.27767 – volume: 92 start-page: 263 year: 2023 ident: B66 article-title: HIV increases the risk of cigarette smoke-induced emphysema through MMP-9 publication-title: J. Acquir Immune Defic. Syndr. doi: 10.1097/QAI.0000000000003125 – volume: 12 start-page: 5 year: 2019 ident: B49 article-title: Iron homeostasis in the lungs-A balance between health and disease publication-title: Pharm. (Basel) doi: 10.3390/ph12010005 – volume: 1865 start-page: 721 year: 2018 ident: B7 article-title: Nrf2-Keap1 signaling in oxidative and reductive stress publication-title: Biochim. Biophys. Acta Mol. Cell Res. doi: 10.1016/j.bbamcr.2018.02.010 – volume: 6 start-page: 198 year: 2015 ident: B62 article-title: Effects of N-acetylcysteine, oral glutathione (gsh) and a novel sublingual form of gsh on oxidative stress markers: A comparative crossover study publication-title: Redox Biol. doi: 10.1016/j.redox.2015.07.012 – volume: 21 start-page: 1 year: 2019 ident: B5 article-title: Therapeutic approaches to Alzheimer's disease through modulation of NRF2 publication-title: Neuromolecular Med. doi: 10.1007/s12017-018-08523-5 – volume: 115 start-page: 1 year: 2018 ident: B43 article-title: Assessment of mitochondrial function following short- and long-term exposure of human bronchial epithelial cells to total particulate matter from a candidate modified-risk tobacco product and reference cigarettes publication-title: Food Chem. Toxicol. doi: 10.1016/j.fct.2018.02.013 – volume: 433 start-page: 33 year: 2018 ident: B9 article-title: The multifaceted role of glutathione S-transferases in cancer publication-title: Cancer Lett. doi: 10.1016/j.canlet.2018.06.028 – volume: 10 start-page: 2787 year: 2019 ident: B61 article-title: Environmental exposures and asthma development: Autophagy, mitophagy, and cellular senescence publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.02787 – volume: 136 start-page: 769 year: 2015 ident: B78 article-title: Oxidative stress–induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2015.01.046 – volume: 18 start-page: 1465 year: 2020 ident: B68 article-title: NRF2-Driven KEAP1 transcription in human lung cancer publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-20-0108 – volume: 22 start-page: 1115 year: 1997 ident: B18 article-title: Redox regulation of NF-kappa B activation publication-title: Free Radic. Biol. Med. doi: 10.1016/s0891-5849(96)00501-1 – volume: 24 start-page: 39 year: 2018 ident: B80 article-title: Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function publication-title: Nat. Med. doi: 10.1038/nm.4447 – volume: 12 start-page: 12943 year: 2020 ident: B15 article-title: Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1 publication-title: Aging doi: 10.18632/aging.103378 – volume: 374 start-page: 1 year: 2023 ident: B24 article-title: Chronic exposure to IQOS results in impaired pulmonary function and lung tissue damage in mice publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2022.11.022 – volume: 122 start-page: 877 year: 2018 ident: B19 article-title: Reactive oxygen species in metabolic and inflammatory signaling publication-title: Circulation Res. doi: 10.1161/CIRCRESAHA.117.311401 – volume: 133 start-page: 144 year: 2019 ident: B63 article-title: Role of GPX4 in ferroptosis and its pharmacological implication publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2018.09.014 – volume: 14 start-page: 645 year: 2018 ident: B16 article-title: Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia publication-title: Redox Biol. doi: 10.1016/j.redox.2017.11.006 – volume: 12 start-page: 1742 year: 2020 ident: B28 article-title: Attenuation of lipopolysaccharide-induced acute lung injury by hispolon in mice, through regulating the TLR4/PI3K/Akt/mTOR and keap1/nrf2/HO-1 pathways, and suppressing oxidative stress-mediated ER stress-induced apoptosis and autophagy publication-title: Nutrients doi: 10.3390/nu12061742 – volume: 9 start-page: 10 year: 2008 ident: B22 article-title: Iron homeostasis and oxidative stress in idiopathic pulmonary alveolar proteinosis: A case-control study publication-title: Respir. Res. doi: 10.1186/1465-9921-9-10 – volume: 60 start-page: 512 year: 2019 ident: B20 article-title: Current status and challenges of NRF2 as a potential therapeutic target for diabetic cardiomyopathy publication-title: Int. heart J. doi: 10.1536/ihj.18-476 – volume: 99 start-page: 151058 year: 2020 ident: B74 article-title: Mitochondria regulation in ferroptosis publication-title: Eur. J. Cell Biol. doi: 10.1016/j.ejcb.2019.151058 – volume: 40 start-page: 60 year: 2014 ident: B38 article-title: E-Cigarettes and cardiovascular risk: Beyond science and mysticism publication-title: Semin. Thromb. Hemost. doi: 10.1055/s-0033-1363468 – volume: 34 start-page: 529 year: 2012 ident: B4 article-title: Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models publication-title: Reprod. Toxicol. doi: 10.1016/j.reprotox.2012.08.001 – volume: 25 start-page: 10 year: 2020 ident: B39 article-title: Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis publication-title: Cell Mol. Biol. Lett. doi: 10.1186/s11658-020-00205-0 – volume: 30 start-page: 286 year: 2007 ident: B59 article-title: Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis publication-title: Eur. Respir. J. doi: 10.1183/09031936.00154006 – volume: 24 start-page: 4771 year: 2018 ident: B34 article-title: Oxidative stress and cancer publication-title: Curr. Pharm. Des. doi: 10.2174/1381612825666190215121712 – volume: 32 start-page: 234 year: 2011 ident: B30 article-title: Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation publication-title: Mol. Asp. Med. doi: 10.1016/j.mam.2011.10.006 – volume: 63 start-page: 59 year: 2018 ident: B73 article-title: Oxidative stress in chronic lung disease: From mitochondrial dysfunction to dysregulated redox signaling publication-title: Mol. Asp. Med. doi: 10.1016/j.mam.2018.08.001 – volume: 79 start-page: 101953 year: 2022 ident: B75 article-title: Resveratrol alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and down-regulating TLR4/NF-κB and TGF-β1/smad3 signalling pathways in rats publication-title: Tissue Cell doi: 10.1016/j.tice.2022.101953 |
| SSID | ssj0000399364 |
| Score | 2.4134004 |
| SecondaryResourceType | review_article |
| Snippet | Oxidative stress is caused by an imbalance in oxidant/antioxidant processes and is a critical process in pulmonary diseases. As no truly effective therapies... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1190817 |
| SubjectTerms | antioxidants inflammation mitochondria oxidative stress Pharmacology pulmonary disease |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NSwMxEA3iyYv4bf0ignixS7tJmm2OKpYiKh4UPAghm01QKLvFtmD_vTPJWlsRvXhbdhM2ZCaZ98jMCyEnEESlEhbFB7lLRGZcYoRzCTRWHsIRs10sFL69k_1Hcf3UeZq76gtzwqI8cJy4lmKZZ6ZIPTgKgHkDfMFbnznLur4ro3opxLw5MhX2YIy7UsQqGWBhquWHLwb1PxmHXUJBIMwWIlEQ7P8JZX5PlpyLPr01slrDRnoeh7tOlly5QU7vo-70tEkfvsqoRk16Su-_FKmnm-T5Bgt6MdWJmlqEBB4KiumbeDRAK08BCNLBTGOZViWt3l-LIAtOY0FJ6DKcDMBxzduU1kc7oy3y2Lt6uOwn9bUKiQUuPE6k8J4DTQKs5GXbc-9Z2-aFKQCZYI1yh3vFeWqcF1xmvOAWUCMAwRzBBtBNvk2Wy6p0u4RKlXXwUhXpZC4ka-eOW5eywiFrlDxvkPRzirWtNcfx6ouBBu6BZtHBLBrNomuzNMjZrM8wKm782voCLTdriWrZ4QX4kK59SP_lQw1y_Gl3DasLj0xM6arJSIfK3g5wsnaD7EQ_mP2KZ6iWJuBLd8FDFsay-KV8fQkK3mlAnkrt_cfo98kKzgimNDB5QJbHbxN3CEhpnB-FRfEB0jUSWw priority: 102 providerName: Directory of Open Access Journals |
| Title | Landscape analysis and overview of the literature on oxidative stress and pulmonary diseases |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37305540 https://www.proquest.com/docview/2825155760 https://pubmed.ncbi.nlm.nih.gov/PMC10250599 https://doaj.org/article/927f2ad1f638495a924fcf7ec28f8605 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PT9swFH5i5bLLNMZ-dEBlpInLyNbarpMcEBoIhKYxcaASh0mW49iAVCWlPyT63_Oe45YVsZ24RbGtJH623_fFft8D-IJOVOXSkvigcIlMjUuMdC7ByrlHd8RtRoHC57_V2UD-vOpfrcEi3VHswMmz1I7ySQ3Gw2_3d_NDnPAHxDjR3373oxtD0p5c4AKQo49LX8E6eqaUMhqcR7gfVmbyxko2sTP_aLrin4KM_3PY8-kRyr980ulbeBPBJPvRWH8D1lz1DvYuGjXq-T67fAyumuyzPXbxqFM934Q_vyjMlw5AMROlSfCiZHSokzYMWO0ZwkM2XCovs7pi9f1tGcTCWRNmEpqMZkMczmY8Z3HDZ_IeBqcnl8dnSUy2kFhkyNNESe8FkidEUF51vfCed21RmhLxCkUu94XPhegZ56VQqSiFRSyJ8LAgCIIkVHyAVlVX7hMwlad9SrWinCqk4t3CCet6vHTEJZUo2tBbdLG2UYmcEmIMNTISMosOZtFkFh3N0oavyzajRofjv7WPyHLLmqShHW7U42sdp6TOeeq5KfFzRYY00SAT9danzvLMZ8jy2rC7sLvGOUcbKaZy9WyiQ7xvH5latw0fm3GwfJRISUNNYkm2MkJW3mW1pLq9CbrevYBH8_zzS7z9FrymHqGDDlxtQ2s6nrkdxE_TohP-O3TC1HgAQ2wb6A |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Landscape+analysis+and+overview+of+the+literature+on+oxidative+stress+and+pulmonary+diseases&rft.jtitle=Frontiers+in+pharmacology&rft.au=Xin+Liu&rft.au=Xiaofan+Wang&rft.au=Jing+Chang&rft.au=Hongmin+Zhang&rft.date=2023-05-26&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=14&rft_id=info:doi/10.3389%2Ffphar.2023.1190817&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_927f2ad1f638495a924fcf7ec28f8605 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |